Continuation and maintenance therapy of early-onset major depressive disorder

Pediatric Drugs

Volumn 7, Issue 4, 2005, Pages 203-217

  Emslie, Graham J ^a,b   Mayes, Taryn L ^a   Ruberu, Maryse ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

BEHAVIOR THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DECISION MAKING; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTERPERSONAL COMMUNICATION; KAPLAN MEIER METHOD; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR DEPRESSION; PRIORITY JOURNAL; PSYCHOTHERAPY; RATING SCALE; RECURRENT DISEASE; RELAPSE; REMISSION; REVIEW; STRESS; SUICIDE;

ADOLESCENT; ALGORITHMS; ANTIDEPRESSIVE AGENTS; CHILD; COGNITIVE THERAPY; DEPRESSIVE DISORDER, MAJOR; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 27744453342     PISSN: 11745878     EISSN: 11745878     Source Type: Journal    
DOI: 10.2165/00148581-200507040-00001     Document Type: Review

References (129)

1. Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 1990; 29: 571-80
2. Brent DA. Correlates of the medical lethality of suicide attempts in children and adolescents. J Am Acad Child Adolesc Psychiatry 1987; 26: 87-91
3. Pfeffer CR, Klerman GL, Hurt SW, et al. Suicidal children grow up: demographic and clinical risk factors for adolescent suicide attempts. J Am Acad Child Adolesc Psychiatry 1991; 30: 609-16
4. Shaffer D, Fisher P, Dulcan MK, et al. The NIMH diagnostic interview schedule for children version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996; 35 (7): 865-77
5. Cassan P, Fava M. Depression and public health: an overview. J Psychosom Res 2002; 53 (4): 849-57
6. Zito JM, Safer DJ, DosReis S, et al. Trends in the prescribing of psychotropic medications in preschoolers. JAMA 2000; 283: 1025-30
7. Emslie GJ, Weinberg WA, Rush AJ, et al. Depressive symptoms by self report in adolescence: phase I of the development of a questionnaire for depression by self-report. J Child Neurol 1990; 3: 114-21
8. Kessler RC, McGonagle KA, Nelson CB, et al. Sex and depression in the national comorbidity survey: II. Cohort effects. J Affect Disord 1994; 30: 15-26
9. Brooks SJ, Kutcher S. Diagnosis and measurement of adolescent depression: a review of commonly utilized instruments. J Child Adolesc Psychopharmacol 2001; 11 (4): 341-76
10. Herjanic B, Reich W. Development of a structured psychiatric interview for children: agreement between child and parent on individual symptoms. J Abnorm Child Psychol 1982; 10: 307-24
11. Costello EJ, Edelbrock CS, Costello AJ. Validity of the NIMH diagnostic interview schedule for children: a comparison between psychiatric and pediatric referrals. J Abnorm Child Psychol 1985; 13 (4): 579-95
12. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children - present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36 (7): 980-8
13. Hodges K, Kline J, Stern L, et al. The development of a child assessment interview for research and clinical use. J Abnorm Child Psychol 1982; 10 (2): 173-89
14. Kovacs M. The interview schedule for children (ISC). Psychopharmacol Bull 1985; 21 (4): 991-4
15. Poznanski EO, Freeman LN, Mokros HB. Children's Depression Rating Scale: revised. Psychopharmacol Bull 1985; 21: 979-89
16. Petti TA. Scales of potential use in the psychopharmacological treatment of depressed children and adolescents. Psychopharmacol Bull 1985; 21: 951-5
17. McKnew D, Cytryn L, Efron A, et al. Offspring of patients with affective disorders. Br J Psychiatry 1979; 134: 148-52
18. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71
19. Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 1984; 40 (6): 1365-7
20. Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985; 21 (4): 995-8
21. Weissman MM, Orvaschel H, Padian N. Children's symptoms and social functioning self report scales. J Nerv Ment Dis 1980; 168: 736-40
22. Birleson P, Hudson I, Buchanan DG, et al. Clinical evaluation of a self-rating scale for depressive disorder in childhood (Depression Self-Rating Scale). J Child Psychol Psychiatry 1987; 28 (1): 43-60
23. LeBlanc JC, Almudeval A, Brooks SJ, et al. Screening for adolescent depression: comparison of the Kutcher Adolescent Depression Scale with the Beck Depression Inventory. J Child Adolesc Psychopharmacol 2002; 12 (2): 113-26
24. Weinberg WA, Rutman J, Sullivan L, et al. Depression in children referred to an educational diagnostic center: diagnosis and treatment. J Pediatr 1973; 83: 1065-72
25. Weinberg WA, Emslie GJ. Weinberg Screening Affective Scales (WSAS and WSAS-SF). J Child Neurol 1988; 3 (4): 294-6
26. Hazell P, O'Connell D, Heathcote D, et al. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 1995; 310: 897-901
27. Kutcher S, Boulos C, Ward B, et al. Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 1994; 33: 686-94
28. Maneeton N, Srisurapanont M. Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized-controlled trials. J Med Assoc Thai 2000; 83 (11): 1367-74
29. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000; 58 (1): 19-36
30. Storosum JG, Elferink AJ, van Zwieten BJ, et al. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. Eur Neuropsychopharmacol 2001; 11 (2): 173-80
31. Depression Guideline Panel. Depression in primary care. Vol. II. Treatment of major depression. In: US Department of Health and Human Services. Clinical practice guideline no. 5: AHCPR publication no. 93-0550. Rockville (MD): US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993
32. Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry 1991; 52 Suppl. 5: 28-34
33. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 851-5
34. Rush AJ, Crismon LC, Toprac M, et al. Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry 1998; 59 Suppl. 20: 73-84
35. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49: 809-16
36. Coryell W, Akiskal HS, Leon AC, et al. The time course of nonchronic major depressive disorder: uniformity across episodes and samples. National Institute of Mental Health Collaborative Program on the Psychobiology of Depression - Clinical Studies. Arch Gen Psychiatry 1994; 51: 405-10
37. Kovacs M, Feinberg TL, Crouse-Novak MA. Depressive disorders in childhood: I. A longitudinal prospective study of characteristics and recovery. Arch Gen Psychiatry 1984; 41: 229-37
38. McCauley E, Myers K, Mitchell J, et al. Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry 1993; 32 (4): 714-22
39. Strober M, Lampert C, Schmidt S, et al. The course of major depressive disorder in adolescents: I. Recovery and risk of manic switching in a follow-up of psychot-ic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 1993; 32 (1): 34-42
40. Emslie GJ, Rush AJ, Weinberg WA, et al. Recurrence of major depressive disorder in hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36: 785-92
41. Keller MB, Lavori PW, Beardslee WR, et al. Depression in children and adoles-cents: new data on 'undertreatment' and a literature review on the efficacy of available treatments. J Affect Disord 1991; 21: 163-71
42. Keller MB, Shapiro RW, Lavori PW, et al. Relapse in major depressive disorder: analysis with the life table. Arch Gen Psychiatry 1982; 39: 911-5
43. Angst J. Natural history and epidemiology of depression. In: Cobb J, Goeting N, editors. Current approaches. Southampton: Duphar Medical Relations, 1990: 1-11
44. Asarnow JR, Goldstein MJ, Carlson GA, et al. Childhood-onset depressive disorders: a follow-up study of rates of rehospitalization and out-of-home placement among child psychiatric inpatients. J Affect Disord 1988; 15: 245-53
45. Eastgate J, Gilmour L. Long-term outcome of depressed children: a follow-up study. Dev Med Child Neurol 1984; 26: 68-72
46. Goodyer I, Germany E, Gowrusankur J, et al. Social influences on the course of anxious and depressive disorders in school-age children. Br J Psychiatry 1991; 158: 676-84
47. Poznanski EO, Krahenbuhl V, Zrull JP. Childhood depression. J Am Acad Child Adolesc Psychiatry 1976; 15: 491-501
48. Garber J, Kriss MR, Koch M, et al. Recurrent depression in adolescents: a follow-up study. J Am Acad Child Adolesc Psychiatry 1988; 27: 49-54
49. Emslie GJ, Rush AJ, Weinberg WA, et al. Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety 1998; 7: 32-9
50. Kovacs M, Feinberg TL, Crouse-Novak MA. Depressive disorders in childhood: II. A longitudinal study of the risk for a subsequent major depression. Arch Gen Psychiatry 1984; 41: 643-9
51. Rao U, Ryan ND, Birmaher B, et al. Unipolar depression in adolescents: clinical outcome in adulthood. J Am Acad Child Adolesc Psychiatry 1995; 34: 566-78
52. Vostanis P, Feehan C, Grattan E, et al. A randomized controlled out-patient trial of cognitive-behavioral treatment for children and adolescents with depression: 9 month follow-up. J Affect Disord 1996; 40 (1-2): 105-16
53. Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 1996; 37 (6): 737-46
54. Rao U, Weissman MM, Martin JA, et al. Childhood depression and risk of suicide: a preliminary report of a longitudinal study. J Am Acad Child Adolesc Psychiatry 1993; 32 (1): 21-7
55. Kovacs M, Goldston D, Gatsonis C. Suicidal behaviors and childhood-onset depressive disorders: a longitudinal investigation. J Am Acad Child Adolesc Psychiatry 1993; 32: 8-20
56. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949-58
57. Rounsaville BJ, Dolinsky ZS, Babor TF, et al. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry 1987; 44: 505-13
58. Schuckit MA, Gold E, Risch C. Plasma cortisol levels following ethanol in sons of alcoholics and controls. Arch Gen Psychiatry 1987; 44: 942-5
59. Clark DB, Kirisci L, Tarter RE. Adolescent versus adult onset and the development of substance use disorders in males. Drug Alcohol Depend 1998; 48: 115-21
60. Rohde P, Lewinsohn M, Seeley JR. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 1991; 100: 214-22
61. Rao U, Ryan ND, Dahl RE, et al. Factors associated with the development of substance use disorder in depressed adolescents. J Am Acad Child Adolesc Psychiatry 1999; 38: 1109-17
62. Rohde P, Lewinsohn PM, Seeley JR. Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry 1996; 35: 101-9
63. Whitmore EA, Mikulich SK, Thompson LL, et al. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperac-tivity disorder, and gender. Drug Alcohol Depend 1997; 47: 87-97
64. King CA, Ghaziuddin N, McGovern L, et al. Predictors of comorbid alcohol and substance abuse in depressed adolescents. J Am Acad Child Adolesc Psychiatry 1996; 35: 743-75
65. Riggs PD, Baker S, Mikulich SK, et al. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry 1995; 34: 764-71
66. Aseltine RH, Gore S, Colten ME. The co-occurrence of depression and substance abuse in late adolescence. Dev Psychopathol 1998; 10: 549-70
67. Clark DB, Kirisci L. Posttraumatic stress disorder, depression, alcohol use disorders and quality of life in adolescents. Anxiety 1996; 2: 226-33
68. Rao U, Daley SE, Hammen C. Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. J Am Acad Child Adolesc Psychiatry 2000; 39: 215-22
69. Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utiliza-tion. Am J Orthopsychiatry 1996; 66: 17-31
70. Bukstein OG, Brent DA, Perper JA, et al. Risk factors for completed suicide among adolescents with a lifetime history of substance abuse: a case-control study. Acta Psychiatr Scand 1993; 88: 403-8
71. Kandal DB, Davies M. Adult sequela of adolescent depressive symptoms. Arch Gen Psychiatry 1986; 43: 255-62
72. Harrington R, Fudge H, Rutter M, et al. Adult outcomes of childhood and adolescent depression. Arch Gen Psychiatry 1990; 47: 465-73
73. Brent DA, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry 1997; 54: 877-85
74. Wilkes TCR, Rush AJ. Case study: adaptations of cognitive therapy for depressed adolescents. J Am Acad Child Adolesc Psychiatry 1988; 27 (3): 381-6
75. Bursuk LI. The effects of a school-based cognitive-behavioral intervention pro-gram on the depression scores of sixth-grade students: a comparison outcome study [abstract]. Diss Abstr Int 1998; 59 (4-A): 1065
76. Vostanis P, Feehan C, Grattan E. Two-year outcome of children treated for depression. Eur Child Adolesc Psychiatry 1998; 7 (1): 12-8
77. Reinecke MA, Ryan NE, DuBois DL. Cognitive-behavioral therpay of depression and depressive symptoms during adolescence: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry 1998; 37: 26-34
78. Clarke GN, Rohde P, Lewinsohn PM, et al. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry 1999; 38 (3): 272-9
79. Clarke GN, Hawkins W, Murphy M, et al. Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a random-ized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry 1995; 34: 312-21
80. Reynolds WM, Coats KI. A comparison of cognitive-behavioral therapy and relaxation training for the treatment of depression in adolescents. J Consult Clin Psychol 1986; 54: 653-60
81. Kahn JS, Kehle TJ, Jenson WR, et al. Comparison of cognitive-behavioral, relaxation, and self-modeling interventions for depression among middle-school students. School Psych Rev 1990; 19: 195-210
82. Lewinsohn PM, Clarke GN, Hops H, et al. Cognitive-behavioral treatment for depressed adolescents. Behav Ther 1990; 21: 385-401
83. Lewinsohn PM, Clarke GN, Rhode P, et al. A course in coping: a cognitive-behavioral approach to the treatment of adolescent depression. In: Hibb ED, Jensen PS, editors. Psychosocial treatments for children and adolescent disor-ders: empirically based strategies for clinical practice. Washington (DC): American Psychiatric Association Press, 1996: 109-35
84. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 1999; 56 (6): 573-9
85. Santor DA, Kusumakar V. Open trial of interpersonal therapy in adolescents with moderate to severe major depression: effectiveness of novice IPT therapists. J Am Acad Child Adolesc Psychiatry 2001; 40 (2): 236-40
86. Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol 1999; 67 (5): 734-45
87. Vitiello B, Jensen PS. Medication development and testing in children and adolescents: current problems, future directions. Arch Gen Psychiatry 1997; 54 (9): 871-6
88. Medicine and Healthcare products Regulatory Agency. News in 2003 [online]. Available from URL: http://www.mhra.gov.uk/news/2003.htm [Accessed 2005 Jul 28]
89. US FDA. Antidepressant use in children, adolescents, and adults [online]. Availa-ble from URL: http://www.fda.gov/cder/drug/antidepressants/ [Accessed 2005 Jul 28]
90. Hughes CW, Emslie GJ, Crimson ML, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 1999; 38 (11): 1442-54
91. Treatment for Adolescents with Depression Study Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized con-trolled trial. JAMA 2004; 292 (7): 807-20
92. Emslie GJ, Rush AJ, Weinberg WA, et al. Double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry 1997; 54: 1031-7
93. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry 2002; 41 (10): 1205-15
94. Keller MB, Ryan ND, Strober M, et al. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001; 40: 762-72
95. Wagner KD, Ambrosini PJ, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA 2003; 290 (8): 1033-41
96. Wagner KD, Robb AS, Findling R, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depresssion in children and adolescents. Am J Psychiatry 2004; 161: 1079-83
97. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 2005; 46 (7): 735-54
98. Thase ME. Rush AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58 Suppl. 13: 23-9
99. Joffe RT, Levitt AJ, Sokolov ST, et al. Response to an open trial of a second SSRI in major depression. J Clin Psychiatry 1996; 57 (3): 114-5
100. Poirier MF, Boyer P. Venlafaxine and paroxetine in treatment-resistant depression: double-blind, randomized comparison. Br J Psychiatry 1999; 60 Suppl. 4: 14-22
101. Montgomery SA. Antidepressants in long-term treatment. Ann Rev Med 1994; 45: 447-57
102. Montgomery SA. Long-term treatment of depression. Br J Psychiatry 1994; 26S: 31-6
103. Evans MD, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992; 49 (10): 802-8
104. Birmaher B, Brent DA, Kolko D, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000; 57 (1): 29-36
105. Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry 1996; 35 (9): 1156-61
106. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47 (12): 1093-9
107. Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992; 149 (6): 795-800
108. Prien RF, Kupfer DJ. Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 1986; 143 (1): 18-23
109. Montgomery SA, Doogan DP, Burnside R. The influence of different relapse criteria on the assessment of long-term efficacy of sertraline. Int Clin Psychopharmacol 1991; 6S: 37-46
110. Cook BL, Helms PM, Smith RE, et al. Unipolar depression in the elderly: reoccurrence on discontinuation of tricyclic antidepressants. J Affect Disord 1986; 10 (2): 91-4
111. Montgomery SA. Efficacy in long-term treatment of depression. J Clin Psychiatry 1996; 57S: 24-30
112. Montgomery SA, Dunbar G. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 1993; 8: 189-95
113. Montgomery SA, Rasmussen JG, Tanghoj P. A 24-week study of 20mg citalopram, 40mg citalopram, and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1993; 8 (3): 181-8
114. Robert P, Montgomery SA. Citalopram in doses of 20-60mg is effective in depression relapse prevention: a placebo-controlled 6 month study. Int Clin Psychopharmacol 1995; 10 Suppl. 1: 29-35
115. Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Ch Adolesc Psychiatry 2004; 43 (11): 1397-405
116. Reimherr FW, Amsterdam JD, Quitkin FM, et al. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998; 155 (9): 1247-53
117. Hirschfeld RM. Antidepressants in long-term therapy: a review of tricyclic anti-depressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 2000; 403: 35-8
118. Franchini L, Gasperini M, Perez J, et al. Dose-response efficacy of partoxetine in preventing depressive recurrences: a randomized, double-blind study. J Clin Psychiatry 1998; 59 (5): 229-32
119. Frank E, Kupfer DJ, Perel JM, et al. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993; 27 (3): 139-45
120. Fava G, Grandi S, Zielezny M, et al. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 1994; 151 (9): 1295-9
121. Fava G, Grandi S, Zielezny M, et al. Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1996; 153 (7): 945-7
122. Fava G, Rafanelli C, Grandi S, et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 1998; 155 (10): 1443-5
123. Fava G, Rafanelli C, Grandi S, et al. Prevention of recurrent depression with cognitive behavioral therapy preliminary findings. Arch Gen Psychiatry 1998; 55: 816-20
124. Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 1999; 56: 829-35
125. Reynolds CF, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychother-apy as maintenance therapies for recurrent major depression. JAMA 1999; 281 (1): 39-45
126. Emslie GJ, Mayes TL. Mood disorders in children and adolescents: psychopharmacological treatment. Biol Psychiatry 2001; 49: 1082-90
127. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993; 150 (Suppl. 4): 1-26
128. Gould MS, Greenberg T, Velting DM, et al. Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003; 42 (4): 386-405
129. Olfson M, Shaffer D, Marcus SC, et al. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003; 60: 978-82